Townsend Letter The Examiner of Alternative Medicine
Alternative Medicine Conference Calendar
Check recent tables of contents


From the Townsend Letter
October 2006


Recent Progress in Clinical Applications
and Research in Fibromyalgia

by Robert W. Bradford, Professor of Medicine, D. Sc. NMD, and Henry W. Allen, Director of Clinical Biochemistry, BRI

Search this site

The article. . . 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12

Table of Contents

(Back to Page 1, Page 2)

81. Wang Y, Aisen P, Casadeval A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun. 1995;63:3131-6.
82. Williamson PR, Wakamatsu K, Ito S. Melanin biosynthesis in Cryptococcus neoformans. J Bacteriol. 1998;180:1570-2.
83. Nosanchuk JD, Casadevall A. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun 1997;65:1836-41.
84. Nyhus KJ, Wilborn AT, Jacobson ES. Ferric iron reduction by Cryptococcus neoformans. Infect Immun. 1997;65:434-8.
85. Huffnagle GB, Chen GH, Curtis JL, et al. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol. 1995;155:3507-16.
86. Wang Y, Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine. Antimicrob Agents Chemother. 1996;40:541-5.
87. Minari A, Hachem R, Raad I. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis. 2001;32:186-90.
88. Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999;28:1071-9.
89. Vidotto V, Clerico M, Franzin L, et al. Fungal colonization in patients with cancer of the upper respiratory tract. Mycopathologia. 1986;96:97-101.
90. Idigoras P, Perez-Trallero E, Pineiro L, et al. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases. 1990-1999. Clin Infect Dis. 2001;32:E158-65.
91. Sebti A, Kiehn TE, Perlin D, et al. Candida dubliniensis at a cancer center. Clin Infect Dis. 2001;32:1034-8.
92. Manfredini L, Garaventa A, Castagnola E, et al. Fungal infections in pediatric oncology. Pediatr Med Chir. 1995;17:435-41.
93. Park KU, Lee HS, Kim CJ, et al. Fungal discitis due to Aspergillus terreus in a patient with acute lymphoblastic leukemia. J Korean Med Sci. 2000;15:704-7.
94. Gunsilius E, Lass-Florl C, Kahler CM, et al. Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients. Ann Hematol. 2001;80:178-9.
95. Quatresooz P, Meiers I, Arrese JE, et al. Clinical case of the month. Disseminated fusariosis in an immunocompromised patient. Rev Med Liege. 2000;55:974-6.
96. Okada H, Hanatani S, Kondo M, et al. Successful treatment of disseminated Fusarium infection in an infant with leukemia. Int J Hematol. 2000;72:494-8.
97. Zmierczak H, Goemaere S, Mielants H, et al. Candida glabrata arthritis: Case report and review of the literature of Candida arthritis. Clin Rheumatol. 1999;18:406-9.
98. Rameh A, Oufroukhi K, Youssef MJ, et al. Cryptococcus neoformans arthritis. A case report. Chir Main. 2000;19:269-71.
99. Acree T, Abreo F, Bagby J. Coccidioidomycosis of the knee diagnosed by fine-needle aspiration: A case report. Diagn Cytopathol. 1998;19:110-2.
100. Kac G, Piriou P, Gueho E, et al. Osteoarthritis caused by Neocosmospora vasinfecta. Med Mycol. 1999;37:213-7.
101. Gunsilius E, Lass-Florl C, Mur E, et al. Aspergillus osteoarthritis in acute lymphoblastic leukemia. Ann Hematol. 1999;78:529-30.
102. Trowbridge J, Ludmer, LM, Riddle VD, et al. Candida lambica polyarthritis in a patient with chronic alcoholism. J Rheumatol. 1999;26:1846-8.
103. Noverr MC, Phare SM, Toews GB, et al. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun. 2001;69:2957-63.
104. Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991;325:354-7.
105. Tokuda T, Ono Y, Nishyiya H, et al. An autopsy case of fungal (Mucor) cerebral aneurysm. Kansenshogaku Zasshi. 1995;69:438-43.
106. Reiss E, Obayashi T, Orle K, et al. Non-culture based diagnostic tests for mycotic infections. Med Mycol. 2000;38 (Suppl 1):147-59.
107. Makimura K, Murayama SY, Yamaguchi H, Detection of a wide range of medically important fungi by the polymerase chain reaction. J Med Microbiol. 1994;40:358-64.
108. Lass-Florl C, Aigner J, Gunsilius E, et al. Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haemato.l 2001;113:180-4.
109. Blunden G, Roch OG, Rogers DJ, et al. Mycotoxins in food. Med Lab Sci. 1991;48:271-82.
110. Agata N, Tanaka H, Shigenobu K, Possible action of cyclopiazonic acid on myocardial sarcoplasmic reticulum: inotropic effects on neonatal and adult rat heart. Br J Pharmacol. 1993;108:571-2.
111. Takahashi M, Tanzawa K, Takahashi S, Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor. J Biol Chem. 1994;269:369-72.
112. Fleckenstein A, Frey M, Fleckenstein-Grun G. Consequences of uncontrolled calcium entry and its prevention with calcium antagonists. Eur Heart J. 1983;Suppl H:43-50.
113. Norred WP, Morrissey RE, Riley RT, et al. Distribution, excretion and skeletal muscle effects of the mycotoxin [14C]cyclopiazonic acid in rats. Food Chem Toxicol. 1985;23:1069-76.
114. Hurne AM, Chai CL, Waring P, Inactivation of rabbit muscle creatine kinase by reversible formation of an internal disulfide bond induced by the fungal toxin gliotoxin, J Biol Chem. 2000;275:25202-6.
115. Liu H, Jackman S, Driscoll H, et al. Immunologic effects of gliotoxin in rats: mechanisms for prevention of autoimmune diabetes mellitus. Ann Clin Lab Sci. 2000;30:366-78.
116. Waring P, Sjaarda A, Lin QH, Gliotoxin inactivates alcohol dehydrogenase by either covalent modification or free radical damage mediated by redox cycling, Biochem Pharmacol. 1995;49:1195-201.
117. Eichner RD, Waring P, Geue AM, et al. Gliotoxin causes oxidative damage to plasmid and cellular DNA. J Biol Chem. 1988;263:3772-7.
118. Siesjo BK, Elmer E, Janelidze S, et al. Role and mechanisms of secondary mitochondrial failure. Acta Neurochir Suppl (Wien). 1999;73:7-13.
119. Clemons KV, Grunig G, Sobel RA, et al. Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol. 2000;122:186-91.
120. Sutton P, Newcombe NR, Waring P, et al. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun. 1994;62:1192-8.
121. Kremery V Jr., Kunova E, Jesenska Z, et al. Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections. Support Care Cancer. 1996;4:39-45.
122. Personal communication. Albert MacKenzie, MD. Los Angeles, CA.
123. Van Burik JA, Myerson D, Schreckhise RW, et al. Panfungal PCR assay for detection of fungal infection in human blood specimens. J Clin Microbiol. 1998;36:1169-75.
124. Ionescu G, Bradford RW, Merk M. Redox and free radical monitoring in the clinical practice. J Integrat Med. 1999;3:73-5.
125. Cooke S. Is it fibromyalgia? Making progress with this difficult to diagnose disease. Caring Magazine. 1997;13(1).
126. Available at: (9/06: Not a valid link.)
127. Available at: (9/06: Page no longer available. Arthritis statistics are available at
128. Available at:
129. Cronan TA, Serber ER, Walen HR, et al. The influence of age on fibromyalgia symptoms. J Aging Health. 2002;14:370-84.
130. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37:1593-601.
131. Edwards JE. Invasive Candida infections – evolution of a fungal pathogen. N Engl J Med. 1991;324:1026-31.
132. Masuoka J. Hazen KC. Differences in the acid-labile component of Candida albicans mannan from hydrophobic and hydrophilic yeast cells. Glycobiology 1999;9:1281-6.
133. Wosten HA. Hydrophobins: multipurpose proteins. Annu Rev Microbiol. 2001;55:625-46.
134. Glee PM, Sundstrom P, Hazen KC. Expression of surface hydrophobic proteins by Candida albicans in vivo. Infect Immun. 1995;63:1373-9.
135. Agata N, Tanaka H, Shigenobu K. Possible action of cyclopiazonic acid on myocardial sarcoplasmic reticulum: inotropic effects on neonatal and adult rat heart. Br J Pharmacol. 1993;108:571-2.
136. Chen SC, Halliday CL, Meyer W. A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med Mycol. 2002;40:333-57.
137. Kurihara K, Miura NN, Uchiyama M, et al., Measurement of blood clearance time by Limulus G test of Candida-water soluble polysaccharide fraction, CAWS, in mice. FEMS Immunol Med Microbiol. 2000;29:69-76.
138. Wasylnka JA, Simmer MI, Moore MM. Differences in sialic acid density in pathogenic and non-pathogenic Aspergillus species. Microbiology. 2001;147:869-77.
139. Takahashi Y, Konishi K, Cisar JO, et al., Identification and characterization of HSA, the gene encoding the sialic acid-binding adhesin of streptococcus gordonii DL1. Infect Immun. 2002;70:1209-18.
140. Kitajma Y. Structural and biochemical characteristics of pathogenic fungus: cell walls, lipids and dimorphism, and action modes of antifungal agents. Nippon Ishinkiin Gakkai Zasshi 2000;41:211-7.
141. Riedel W, Neeck G. Nociception, pain, and antinociception: current concepts. Z Rheumatol. 2001;60:404-15.

Back to Page 1

Consult your doctor before using any of the treatments found within this site.

Subscriptions are available for Townsend Letter, the Examiner of Alternative Medicine magazine, which is published 10 times each year.

Search our pre-2001 archives for further information. Older issues of the printed magazine are also indexed for your convenience.
1983-2001 indices ; recent indices

Once you find the magazines you'd like to order, please use our convenient form, e-mail, or call 360.385.6021 (PST).


Order back issues
Advertise with TLDP!
Visit our pre-2001 archives
© 1983-2006 Townsend Letter for Doctors & Patients
All rights reserved.
Web site by Sandy Hershelman Designs
September 11, 2006